ALTHOUGH it has been generally recognized that atherosclerosis is associated with a deposition of calcium in the arterial wall, the pathogenic significance of this calcification remains unclear. In recent years, a number of calcium-chelating agents, lanthanum chloride, and organic calcium antagonists have been shown to exert antiatherogenic effects in animals with dietary hypercholesterolemia. This brief review discusses possible interrelations between arterial calcification and atherogenesis, and summarizes some of the data in the literature on the effects of chelating and calcium antagonistic agents.
Deposition of calcium salts in the walls of human arteries begins in childhood and progresses with age. Electron microscopic studies of human atherosclerotic arteries have shown that calcification in the media and intima is associated with extracellular membranous vesicles structurally resembling matrix vesicles in bone and other calcifying tissues. 1 These vesicles contain noncristalline particles and needle-shaped crystals that have the diffraction patterns of apatite. The membranous structures occur in the vicinity of degenerating cells that enclose similar vesicular formations. This suggests that calcifying vesicles represent the debris of mitochondria and other organelles from degenerating medial and intimal cells. The biochemical composition of the membranes has not yet been determined, but it appears likely that phospholipids constitute an important component. It is of interest that atheromatous lesions contain a vitamin K-dependent (y-carboxyglutamic acid-containing) calcium-binding protein that appears to be functionally analogous but structurally dissimilar to osteocalcin.' Like y-carboxyglutamic acid-containing proteins of the blood clotting system, this protein may bind calcium and phospholipid and play a role in regulating the calcification of atherosclerotic plaques. 4 In these normolipidemic animals atherosclerotic lesions appear only months after fibromuscular changes, cell necrosis, and calcifications have developed. Recent findings with regard to the influence of mechanical factors on atherogenesis suggest that arterial stiffness may play a role in the localization and development of atheromas. The relationship between the physical properties of arteries, fluid mechanics, and atherogenesis will require further investigative attention. In addition, the possibility must be considered that crystalline deposits alter the deformability of atheromatous lesions. In coronary arteries, vessels subjected to continual bending movements, crystalline bodies could be traumatic to surrounding soft tissues and cause acute structural changes such as plaque hemorrhage or rupture. It has been recently reemphasized that the dense neovascularization of atheromas may render the artery susceptible to intramural hemorrhage, a possible mechanism of coronary thrombosis. 6 Recently, evidence has accumulated indicating that calcium antagonists may protect muscle and nonmuscle cells by a variety of pathophysiologic processes. Protective effects have been reported in ischemic, cytotoxic, and degenerative syndromes involving skeletal muscle, myocardium, brain, liver, kidney, intes-tine, and the eye.7 The fact that calcium antagonists have a protective effect supports the notion that excessive calcium uptake, in particular mitochondrial calcium overload, plays a role in mediating cell death after various insults. An important question is whether there are membrane physiologic alterations in atherosclerosis that might favor an excessive uptake of calcium. It is well established that modest changes in membrane lipids may alter the functional characteristics of membrane proteins such as ion channels, ion transporters, and receptors. contribute to the stimulation of a fibroproliferative response.
If cell necrosis is an important process in the formation of atheroma and if cell death is mediated in part by changes in membranes that facilitate the intracellular accumulation of calcium, drugs capable of reducing calcium uptake might exert antiatherogenic effects. Almost 20 years ago, Wartman et al. 12 treated cholesterol-fed rabbits with subcutaneous injections of magnesium EDTA and concluded that this chelating agent suppressed the deposition of collagen and elastin in the arteries. Unfortunately, Wartman's experiments have to my knowledge never been repeated, but other chelating agents were subsequently tested for their antiatherogenic effects. Kramsch et al. 1 ' administered diphosphonic acid and thiophene derivatives to rabbits fed a high-cholesterol diet. The treatments did not influence serum cholesterol or triglycerides, but inhibited calcification, lipid accumulation, and plaque formation in arteries. In addition, these investigators demonstrated that LaCL3 exerted antiatherogenic effects in rabbits and monkeys. '3 In view of our considerations concerning altered calcium uptake in atherosclerosis and the therapeutic results obtained with chelating agents, we evaluated the effects of nifedipine, a calcium antagonist, on atherogenesis in rabbits with diet-induced atheroscleroSiS. 14 Rabbits were fed a 2% cholesterol diet for 8 weeks with or without treatment with oral nifedipine (40 mg/rabbit/day). High-dose oral nifedipine was well tolerated and produced modest transient hypotensive effects. Compared with rabbits receiving placebo, treated animals exhibited highly significant reductions in sudanophilic lesions, aortic total cholesterol, and aortic calcium. As with the chelating agents, the drug did not influence the hyperlipidemic response to the diet. Our findings were subsequently confirmed by Willis et al. ,''who demonstrated that high-dose nicardipine and nifedipine produced substantial reductions in aortic lesions, aortic total cholesterol, and aortic triglyceride in cholesterol-fed rabbits. In another study, low-dose nifedipine (2 mg/rabbit/day) was reported to exert antiatherogenic effects in rabbits, although the number of animals studied was small. ' The excellent assistance of Patricia Farrell in the preparation of this manuscript is gratefully acknowledged.
